34 related articles for article (PubMed ID: 2258457)
1. Lessons of the month 2: A case of inappropriate drug-drug interaction in kidney transplant.
Tan MH; Yee SY; Yahya R
Clin Med (Lond); 2022 Mar; 22(2):169-171. PubMed ID: 35304379
[TBL] [Abstract][Full Text] [Related]
2. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
Spina E; Pisani F; Perucca E
Clin Pharmacokinet; 1996 Sep; 31(3):198-214. PubMed ID: 8877250
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine auto- and hetero-induction complicating clinical care.
Onady AA; Calabrese JR
J Clin Psychopharmacol; 1989 Oct; 9(5):387-8. PubMed ID: 2507594
[No Abstract] [Full Text] [Related]
4. [Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].
Cottencin O; Regnaut N; Thévenon-Gignac C; Thomas P; Goudemand M; Debruille C; Robert H
Encephale; 1995; 21(2):141-5. PubMed ID: 7781585
[TBL] [Abstract][Full Text] [Related]
5. Deconstructing a medication regimen.
Preskorn SH
J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
[No Abstract] [Full Text] [Related]
6. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
Tohen M; Castillo J; Pope HG; Herbstein J
J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
[TBL] [Abstract][Full Text] [Related]
7. Diltiazem effect on carbamazepine levels in manic depression.
Gadde K; Calabrese JR
J Clin Psychopharmacol; 1990 Oct; 10(5):378-9. PubMed ID: 2258457
[No Abstract] [Full Text] [Related]
8. Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital.
Steckler TL
J Clin Psychopharmacol; 1994 Oct; 14(5):336-9. PubMed ID: 7806689
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
10. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
Potter WZ; Ketter TA
Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S51-6. PubMed ID: 8500079
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
